Clinical TrialsSearch results
Number of results: 202
Recruiting
- Efficacy of the anteromedial-cortex view in treating trochanteric fractures.
- Trochanteric fractures
- Kanezaki Shozo
- 2023-01-22
Other
- Establishment of quality of care among hospitals in digestive surgery
- Patients who underwent elective digestive surgery
- National Hospital Organization Kumamoto Medical Center
- 2008-10-02
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Evaluation of feasibility and accuracy of diagnosis using sentinel node biopsy in early gastric cancer(JCOG0302, GCSSG-SNB)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-08-15
Other
- Examination of the rating system of peripheral neuropathy by oxaliplatin, paclitaxel using the nerve conduction survey instrument and nab paclitaxel
- Esophageal cancer, gastric cancer, colorectal cancer, pancreatic cancer
- Takashi Inagaki
- 2022-01-13
Other
- Exercise and Life Functioning in Patients with Congestive Heart Failure ; A Rehabilitation Cohort Study.
- Patients with congestive heart failure
- Nagoya University School of Health Sciences
- 2007-12-01
Other
- Feasibility study of adjuvant chemotherapy consisting of FEC(fluoraouracil, epirubicin and cyclophosphamide) followed by DH(docetaxel+herceptin) for patients with HER2 positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17
Other
- Feasibility study of adjuvant chemotherapy with S-1 in elderly patients with non-small-cell lung cancer
- non-small-cell lung cancer
- Lung Oncology Group in Kyushu, Japan (LOGIK)
- 2009-08-25
Other
- Feasibility study of Capecitabine as adjuvant chemotherapy for stage III colon cancer including RS cancer.
- stage III colon cancer including RS cancer
- KSCC
- 2008-10-22
Other
- Feasibility study of TC(docetaxel+Cyclophosphamide)as adjuvant chemotherapy for intermediate risk primary breast cancer with HER2-negative and ER-positive tumor(KBC-SG 0803)
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2008-12-17